Betty Lane didn’t have a whole lot of options left in terms of lung cancer treatment when her doctor Cancer Center in Nashville suggested that they try a drug normally used to treat breast cancer.
Lane’s lung tumor had revealed a glitch in a gene more commonly abnormal in breast and gastric tumors, resulting in a mutant form of a protein that could be targeted by the drug Herceptin. “I feel very fortunate,” says Lane, 55, whose cancer is now shrinking, “to live in an age and a time when this is happening.”
Lane is a prime example of the promise of personalized medicine, which matches treatments to patients based on their genetic and other biological information.
Read the full article here: The Personalization of Medicine
